Abstract
The scientific breakthrough proving that antiretroviral therapy (ART) can halt heterosexual HIV transmission came in the form of a landmark clinical trial conducted among serodiscordant couples. Study findings immediately informed global recommendations for the use of treatment as prevention in serodiscordant couples. The extent to which these findings are generalizable to other key populations or to groups exposed to HIV through nonsexual transmission routes (i.e., anal intercourse or unsafe injection of drugs) has since driven a large body of research. This review explores the history of HIV research in serodiscordant couples, the implications for management of couples, subsequent research on treatment as prevention in other key populations, and challenges in community implementation of these strategies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
(Inserm-ANRS) FNI for H and MR-FNA for R on A and VH The ARNS 12249 TasP (Treatment as Prevention) Trial in Hlabisa Sub-district, KwaZulu-Natal, South Africa
(PEPFAR) PEP for AR, Foundation B& MG, Disease NI of A and I, et al (2017) HPTN071 (PopART) 90:90:90 Lessons learnt
(UNAIDS) TJUNP on H (2009) Report of the UNAIDS HIV Prevention Reference Group Meeting
Abbas UL, Anderson RM, Mellors JW (2006) Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in resource-limited settings. J Acquir Immune Defic Syndr 41:632–641. https://doi.org/10.1097/01.qai.0000194234.31078.bf
Abuelezam NN, McCormick AW, Fussell T et al (2016) Can the heterosexual HIV epidemic be eliminated in South Africa using combination prevention? A modeling analysis. Am J Epidemiol 184:239. https://doi.org/10.1093/aje/kwv344
Abu-Raddad LJ, Magaret AS, Celum CL et al (2008) Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS One 3:e2230–e2230. https://doi.org/10.1371/journal.pone.0002230
Ahmed S, Lutalo T, Wawer M et al (2001) HIV incidence and sexually transmitted disease prevalence associated with condom use: a population study in Rakai, Uganda. AIDS 15:2171–2179. https://doi.org/10.1097/00002030-200111090-00013
Allen S, Tice J, Van de Perre P et al (1992) Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa. BMJ 304:1605
Allen S, Meinzen-Derr J, Kautzman M et al (2003) Sexual behavior of HIV discordant couples after HIV counseling and testing. AIDS 17:733–740. https://doi.org/10.1097/00002030-200303280-00012
Anderson S-J, Cherutich P, Kilonzo N et al (2014) Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study. Lancet 384:249–256. https://doi.org/10.1016/S0140-6736(14)61053-9
Andrews CD, Heneine W (2015) Cabotegravir long-acting for HIV-1 prevention. Curr Opin HIV AIDS 10:258–263. https://doi.org/10.1097/COH.0000000000000161
Atun R, Chang AY, Ogbuoji O et al (2016) Long-term financing needs for HIV control in sub-Saharan Africa in 2015-2050: a modelling study. BMJ Open 6:e009656–e009656. https://doi.org/10.1136/bmjopen-2015-009656
Auvert B, Taljaard D, Lagarde E et al (2005) Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med 2:e298–e298. https://doi.org/10.1371/journal.pmed.0020298
Baernighausen T, Bloom DE, Humair S (2016) Human resources for treating HIV/AIDS: are the preventive effects of antiretroviral treatment a game changer? PLoS One 11:1–24. https://doi.org/10.1371/journal.pone.0163960
Baeten JM, Kahle EM, Lingappa JR, et al (2011) Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med 3:77ra29-77ra29
Baeten JM, Donnell D, Ndase P et al (2012) Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 367:399–410. https://doi.org/10.1056/NEJMoa1108524
Baeten JM, Heffron R, Kidoguchi L et al (2016) Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1–Serodiscordant couples: a prospective implementation study in Kenya and Uganda. PLoS Med 13:e1002099–e1002099. https://doi.org/10.1371/journal.pmed.1002099
Baggaley RF, Boily M-C, White RG, Alary M (2006) Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis. AIDS 20:805–812. https://doi.org/10.1097/01.aids.0000218543.46963.6d
Baggaley RF, White R, Boily M-C (2010) HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol 39:1048–1063
Bailey RC, Moses S, Parker CB et al (2007) Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369:643–656. https://doi.org/10.1016/S0140-6736(07)60312-2
Bedelu M, Ford N, Hilderbrand K, Reuter H (2007) Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care. J Infect Dis 196(Suppl):S464–S468. https://doi.org/10.1086/521114
Bellan SE, Fiorella KJ, Melesse DY et al (2013) Extra-couple HIV transmission in sub-Saharan Africa: a mathematical modelling study of survey data. Lancet 381:1561–1569. https://doi.org/10.1016/S0140-6736(12)61960-6
Bellan SE, Dushoff J, Galvani AP et al (2015) Reassessment of HIV-1 acute phase infectivity: accounting for heterogeneity and study design with simulated cohorts. PLoS Med 12:e1001801–e1001801. https://doi.org/10.1371/journal.pmed.1001801
Bendavid E, Wood R, Katzenstein DA et al (2009) Expanding antiretroviral options in resource-limited settings--a cost-effectiveness analysis. J Acquir Immune Defic Syndr 52:106–113. https://doi.org/10.1097/QAI.0b013e3181a4f9c4
Bendavid E (2010) Comparative effectiveness of HIV testing and treatment in highly endemic regions. Arch Intern Med 170(15):1347
Bigna JJR, Plottel CS, Koulla-Shiro S (2016) Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count. Infect Dis Poverty 5:85. https://doi.org/10.1186/s40249-016-0179-9
Birungi J, Min JE, Muldoon KA et al (2015) Lack of effectiveness of antiretroviral therapy in preventing HIV infection in serodiscordant couples in Uganda: an observational study. PLoS One 10:1–14. https://doi.org/10.1371/journal.pone.0132182
Blower S, Gershengorn H, Grant R (2000) A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science 287:650–654
Boily M-C, Baggaley R, Wang L, Masse B (2009) Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect …
Bond V, Hoddinott G, Viljoen L et al (2016) Good health and moral responsibility: key concepts underlying the interpretation of treatment as prevention in South Africa and Zambia before rolling out universal HIV testing and treatment. AIDS Patient Care STDs 30:425–434. https://doi.org/10.1089/apc.2016.0114
Brookmeyer R, Boren D, Baral SD et al (2014) Combination HIV prevention among MSM in South Africa: results from agent-based modeling. PLoS One 9:e112668. https://doi.org/10.1371/journal.pone.0112668
Brown LB, Havlir DV, Ayieko J et al (2016) High levels of retention in care with streamlined care and universal test and treat in East Africa. AIDS 30:2855–2864. https://doi.org/10.1097/QAD.0000000000001250
Butler AR, Smith JA, Polis CB et al (2013) Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk. AIDS 27:105–113. https://doi.org/10.1097/QAD.0b013e32835a5a52
Callander D, Stoové M, Carr A et al (2016) A longitudinal cohort study of HIV “treatment as prevention” in gay, bisexual and other men who have sex with men: the treatment with Antiretrovirals and their impact on positive and negative men (TAIPAN) study protocol. BMC Infect Dis 16:752. https://doi.org/10.1186/s12879-016-2073-2
Carpenter LM, Kamali A, Ruberantwari A et al (1999) Rates of HIV-1 transmission within marriage in rural Uganda in relation to the HIV sero-status of the partners. AIDS 13:1083–1089. https://doi.org/10.1097/00002030-199906180-00012
Celum C, Wald a LJR et al (2010) Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 362:427–439. https://doi.org/10.1056/NEJMoa0904849
Chan PA, Rose J, Maher J et al (2015) A latent class analysis of risk factors for acquiring HIV among men who have sex with men: implications for implementing pre-exposure prophylaxis programs. AIDS Patient Care STDs 29:597–605. https://doi.org/10.1089/apc.2015.0113
Charlebois ED, Das M, Porco TC, Havlir DV (2011) The effect of expanded antiretroviral treatment strategies on the HIV epidemic among men who have sex with men in San Francisco. Clin Infect Dis 52:1046–1049. https://doi.org/10.1093/cid/cir085
Chemaitelly H, Cremin I, Shelton J et al (2012) Distinct HIV discordancy patterns by epidemic size in stable sexual partnerships in sub-Saharan Africa. Sex Transm Infect 88:51–57. https://doi.org/10.1136/sextrans-2011-050114
Chemaitelly H, Shelton JD, Hallett TB, Abu-Raddad LJ (2013) Only a fraction of new HIV infections occur within identifiable stable discordant couples in sub-Saharan Africa. AIDS 27:251–260. https://doi.org/10.1097/QAD.0b013e32835ad459
Chirawu P, Langhaug L, Mavhu W et al (2010) Acceptability and challenges of implementing voluntary counselling and testing (VCT) in rural Zimbabwe: evidence from the Regai Dzive Shiri Project. AIDS Care 22:81–88. https://doi.org/10.1080/09540120903012577
Choopanya K, Martin M, Suntharasamai P et al (2013) Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 381:2083–2090. https://doi.org/10.1016/S0140-6736(13)61127-7
Coburn BJ, Okano JT, Blower S (2013) Current drivers and geographic patterns of HIV in Lesotho: implications for treatment and prevention in sub-Saharan Africa. BMC Med 11:224. https://doi.org/10.1186/1741-7015-11-224
Cohen MS, Gay CL (2010) Treatment to prevent transmission of HIV-1. Clin Infect Dis 50:S85–S95
Cohen MS, Hoffman IF, Royce RA et al (1997) Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Res Group Lancet (London, England) 349:1868–1873
Cohen MS, Gay CL, Kashuba ADM et al (2007) Antiretroviral therapy to prevent the sexual transmission of HIV-1. Ann Intern Med 146:591–602
Cohen MS, Chen YQ, McCauley M et al (2011) Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365:493–505
Cohen MS, Smith MK, Muessig KE et al (2013) Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet 6736:1–10. https://doi.org/10.1016/S0140-6736(13)61998-4
Cohen MS, Chen YQ, McCauley M et al (2016) Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med 375:830–839. https://doi.org/10.1056/NEJMoa1600693
Colvin CJ, Harrison A, Haberer JE, Bangsberg DR (2015) Broadening the debate over HIV and hormonal contraception. Lancet Infect Dis 15:135–136. https://doi.org/10.1016/S1473-3099(14)71076-X
Control C for D Botswana Combination Prevention Project (BCPP) – NCT01965470
Cori A, Ayles H, Beyers N et al (2014) HPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical model. PLoS One 9:e84511. https://doi.org/10.1371/journal.pone.0084511
Council O of ARA (2016) Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents developed by the DHHS panel on antiretroviral guidelines for adults
Courtenay WH (2000) Constructions of masculinity and their influence on men’s Well-being: a theory of gender and health. Soc Sci Med 50:1385–1401
Cummings DAT, Mehta SH (2016) Modeling interactions between HIV interventions in key populations in India (R21AI116296)
Curran K, Baeten JM, Coates TJ et al (2012) HIV-1 prevention for HIV-1 serodiscordant couples. Curr HIV/AIDS Rep 9:160–170
Darroch JE, Singh S (2013) Trends in contraceptive need and use in developing countries in 2003, 2008, and 2012: an analysis of national surveys. Lancet 381:1756–1762. https://doi.org/10.1016/S0140-6736(13)60597-8
de Vincenzi I, HIV ESG on HT of (1994) A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Engl J Med 331:341–346
De Vos AS, Prins M, Coutinho RA et al (2014) Treatment as prevention among injecting drug users; extrapolating from the Amsterdam cohort study. AIDS 28:911–918. https://doi.org/10.1097/QAD.0000000000000190
Dimitrov D, Kublin JG, Ramsey S, Corey L (2015) Are clade specific HIV vaccines a necessity? An analysis based on mathematical models. EBioMedicine 2:2062–2069. https://doi.org/10.1016/j.ebiom.2015.11.009
Donnell D, Baeten JM, Bumpus NN et al (2014) HIV protective efficacy and correlates of Tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. JAIDS J Acquir Immune Defic Syndr 66:340–348. https://doi.org/10.1097/QAI.0000000000000172
Dunkle K, Stephenson R, Karita E, Chomba E (2008) New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet 371:2183
Dunkle KL, Wong FY, Nehl EJ et al (2013) Male-on-male intimate partner violence and sexual risk behaviors among money boys and other men who have sex with men in shanghai, China. Sex Transm Dis 40(5):362. https://doi.org/10.1097/OLQ.0b013e318283d2af
Dutta A, Barker C, Kallarakal A (2015) The HIV treatment gap: estimates of the financial resources needed versus available for scale-up of antiretroviral therapy in 97 countries from 2015 to 2020. PLoS Med 12:1–43. https://doi.org/10.1371/journal.pmed.1001907
Duwal S, Winkleman S, Schutte C, von Kleist M (2015) Optimal treatment strategies in the context of ‘Treatment for Prevention’ against HIV-1 in resource-poor settings. PLoS Comput Biol 11(4):e1004200. https://doi.org/10.1371/journal.pcbi.1004200
Eaton JW, Johnson LF, Salomon JA, Bärnighausen T, Bendavid E, Bershteyn A, Bloom DE, Cambiano V, Fraser C, Hontelez JAC, Humair S, Klein DJ, Long EF, Phillips AN, Pretorius C, Stover J, Wenger EA, Williams BG, Hallett TB, Bartlett J (2012) HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med 9(7):e1001245
Eaton JW, Menzies NA, Stover J et al (2014) Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Heal 2:e23. https://doi.org/10.1016/S2214-109X(13)70172-4
El-sadr WM, Serwadda DM, Sista N, Cohen MS (2013) HIV prevention: great achievements, more challenges ahead. J Acquir Immune Defic Syndr 63:115–116. https://doi.org/10.1097/QAI.0b013e318299c3d9
Eshleman S, Hudelson S, Redd A et al (2011) Analysis of genetic linkage of HIV from couples enrolled in the HIV prevention trials network 052 trial. J Infect Dis 204:1918–1926
Eyawo O, de Walque D, Ford N et al (2010) HIV status in discordant couples in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Infect Dis 10:770–777. https://doi.org/10.1016/S1473-3099(10)70189-4
Fowke KR, Nagelkerke NJ, Kimani J et al (1996) Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 348:1347–1351. https://doi.org/10.1016/S0140-6736(95)12269-2
Fraser H, Mukandavire C, Martin NK, et al (2016) HIV treatment as prevention among people who inject drugs – a re-evaluation of the evidence. Int J Epidemiol dyw180-dyw180. doi: https://doi.org/10.1093/ije/dyw180
Gaolathe T, Wirth KE, Holme MP et al (2016) Botswana’s progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey. Lancet HIV 3:e221–e230. https://doi.org/10.1016/S2352-3018(16)00037-0
Gardner E, McLees M, Steiner J et al (2011) The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 52:793–800
Geffen N, Robinson M, Venter F, Low M (2014) One size doesn’t fit all: tailoring adult antiretroviral treatment. South Afr J HIV Med 15:77–78. https://doi.org/10.7196/SAJHIVMED.1095
Gisslen M, Svedhem V, Lindborg L, et al (2016) Sweden, the first country to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90-90-90 continuum of HIV care targets. HIV Med 2016–2018. doi: https://doi.org/10.1111/hiv.12431
Goldman DP, Juday T, Seekins D, Linthicum MT, Romley JA (2014) Early HIV treatment in the United States prevented nearly 13,500 infections per year during 1996–2009. Health Aff 33(3):362–369
Goodreau SM, Carnegie NB, Vittinghoff E, Lama JR, Sanchez J, Grinsztejn B, Koblin BA, Mayer KH, Buchbinder SP, Sullivan PS (2012) What drives the US and Peruvian HIV epidemics in men who have sex with men (MSM)? PLoS One 7(11):e50522
Grabowski MK, Lessler J, Redd AD et al (2014) The role of viral introductions in sustaining community-based HIV epidemics in rural Uganda: evidence from spatial clustering, phylogenetics, and egocentric transmission models. PLoS Med 11:e1001610. https://doi.org/10.1371/journal.pmed.1001610
Granich RM, Gilks C, Dye C et al (2009) Universal voluntary HIV testing and immediate antiretroviral therapy--author’s reply. Lancet 373:48–57
Granich RM, Kahn J, Bennett R et al (2012) Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050. PLoS One 7:e30216–e30216
Gray RH, Kiwanuka N, Quinn TC, et al (2000) Male circumcision and HIV acquisition and transmission : cohort studies in Rakai , Uganda
Gray RH, Wawer MJ, Brookmeyer R et al (2001) Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357:1149–1153
Gray RH, Kigozi G, Serwadda D et al (2007) Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369:657–666. https://doi.org/10.1016/S0140-6736(07)60313-4
Gray RH, Ssempiija V, Shelton J et al (2011) The contribution of HIV-discordant relationships to new HIV infections in Rakai, Uganda. AIDS 25:863–865
Group TA 12136 S (2015) A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med 373:808–822. https://doi.org/10.1056/NEJMoa1507198
Grulich A, Wilson DP (2010) Is antiretroviral therapy modifying the HIV epidemic? Lancet 376:1824–author reply 1825
Gunn JKL, Asaolu IO, Center KE et al (2016) Antenatal care and uptake of HIV testing among pregnant women in sub-Saharan Africa: a cross-sectional study. J Int AIDS Soc 19:20605. https://doi.org/10.7448/ias.19.1.20605
Haberer JE, Baeten JM, Campbell J et al (2013) Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of Serodiscordant couples in East Africa. PLoS Med 10:e1001511. https://doi.org/10.1371/journal.pmed.1001511
Hallett TB, Eaton JW (2013) A side door into care Cascade for HIV-infected patients ? AIDS 63:228–232
Hallett TB, Baeten JM, Heffron R et al (2011) Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. PLoS Med 8:e1001123. https://doi.org/10.1371/journal.pmed.1001123
Harris C, Small CB, Klein RS et al (1983) Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome. N Engl J Med 308:1182–1183
Hayes RJ, Ayles H, Beyers N et al (2014) HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment – a study protocol for a cluster randomised trial. Trials 15:57. https://doi.org/10.1186/1745-6215-15-57
Hayes R, Floyd S, Schaap A et al (2017) A universal testing and treatment intervention to improve HIV control: one-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial. PLoS Med 14:e1002292–e1002292. https://doi.org/10.1371/journal.pmed.1002292
Heaton LM, Bouey PD, Joe F, Stover J, Fowler TB, Lyerla R, Mahy M (2015) Estimating the impact of the US President’s emergency plan for AIDS relief on HIV treatment and prevention programmes in Africa. Sex Transm Infect 91(8):615–620
Heffron R, Celum C, Baeten JM et al (2012) Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 12:19–26. https://doi.org/10.1016/S1473-3099(11)70247-X
HIV Prevention Trials Network Population Effects of Antiretroviral Therapy to Reduce HIV Transmission (PopART) (2013)
HIV Vaccine Trials Network (2016) HVTN 702
Hollingsworth T, Anderson R, Fraser C (2008) HIV-1 transmission, by stage of infection. J Infect Dis 198:687–693
Hontelez JAC, Lurie MN, Bärnighausen T, Bakker R, Baltussen R, Tanser F, Hallett TB, Newell M-L, de Vlas SJ, Ford N (2013) Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study. PLoS Med 10(10):e1001534
Hughes JP, Baeten JM, Lingappa JR et al (2012) Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples. J Infect Dis 205:358–365. https://doi.org/10.1093/infdis/jir747
ICF International (2012) HIV-related Knowledge and behaviors among people living with HIV in eight high HIV prevalence countries in sub-Saharan Africa: DHS analytical studies 29. Int Health Dev. doi: https://doi.org/10.13140/RG.2.1.2355.1524
INSIGHT START Study Group, Lundgren J (2015) Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med 373:1–13. https://doi.org/10.1056/NEJMoa1506816
Iwuji CC, Orne-Gliemann J, Tanser F et al (2013) Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (treatment as prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a clus. Trials 14:230. https://doi.org/10.1186/1745-6215-14-230
Iwuji CC, Orne-Gliemann J, Larmarange J et al (2017) Universal test and treat and the HIV epidemic in rural South Africa (under review). N Engl J Med
Jackson A, McGowan I (2015) Long-acting rilpivirine for HIV prevention. Curr Opin HIV AIDS 10:253–257. https://doi.org/10.1097/COH.0000000000000160
Jain V, Byonanebye DM, Amanyire G et al (2014) Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/μl in rural Uganda. AIDS 28:2241–2249. https://doi.org/10.1097/QAD.0000000000000401
Jain V, Chang W, Byonanebye DM, et al (2015) Estimated costs for delivery of HIV antiretroviral therapy to individuals with CD4+ T-cell counts >350 cells/uL in rural Uganda. PLoS One 10:1–15. doi: https://doi.org/10.1371/journal.pone.0143433
Jansson J, Kerr CC, Wilson DP, (2014) Predicting the population impact of increased HIV testing and treatment in Australia. Sexual Health
Jewell B, Baeten JM, Haberer J, et al (forthcoming-a) The importance of adherence to pre-exposure prophylaxis for HIV-1 prevention among serodiscordant couples in East Africa: a modelling study
Jewell B, Beaten JM, Haberer J, et al (forthcoming-b) Pre-exposure prophylaxis can be cost-saving for high-risk HIV-serodiscordant couples
Jewkes R, Morrell R (2010) Gender and sexuality: emerging perspectives from the heterosexual epidemic in South Africa and implications for HIV risk and prevention. J Int AIDS Soc 13:6. https://doi.org/10.1186/1758-2652-13-6
Jiwatram-Negrón T, El-Bassel N (2014) Systematic review of couple-based HIV intervention and prevention studies: advantages, gaps, and future directions. AIDS Behav 18:1864–1887. https://doi.org/10.1007/s10461-014-0827-7
Johnson LF, Mossong J, Dorrington RE et al (2013) Life expectancies of south African adults starting antiretroviral treatment: collaborative analysis of cohort studies. PLoS Med 10:e1001418–e1001418. https://doi.org/10.1371/journal.pmed.1001418
Jones A, Cremin Í, Abdullah F et al (2014) Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination prevention. Lancet 384:272–279. https://doi.org/10.1016/S0140-6736(13)62230-8
Joseph SB, Swanstrom R, Kashuba ADM, Cohen MS (2015) Bottlenecks in HIV-1 transmission: insights from the study of founder viruses. Nat Rev Microbiol 13:414–425. https://doi.org/10.1038/nrmicro3471
Kahle EM, Hughes JP, Lingappa JR et al (2013) An empiric risk scoring tool for identifying high-risk heterosexual HIV-1–Serodiscordant couples for targeted HIV-1 prevention. JAIDS J Acquir Immune Defic Syndr 62:339–347. https://doi.org/10.1097/QAI.0b013e31827e622d
Kakaire T, Schlech W, Coutinho A et al (2016) The future of financing for HIV services in Uganda and the wider sub-Saharan Africa region: should we ask patients to contribute to the cost of their care? BMC Public Health 16:896. https://doi.org/10.1186/s12889-016-3573-0
Kato M, Granich R, Bui DD et al (2013) The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: towards elimination of HIV transmission. J Acquir Immune Defic Syndr 63:e142. https://doi.org/10.1097/QAI.0b013e31829b535b
Kurth AE, Celum CL, Baeten JM et al (2011) Combination HIV prevention: significance, challenges, and opportunities. Curr HIV/AIDS Rep 8:62–72. https://doi.org/10.1007/s11904-010-0063-3
Labor SAD of (2009) South Africa Department of Labor. Skills shortages in South Africa: case studies of key professions. Cape Town, South Africa
Lankowski AJ, Siedner MJ, Bangsberg DR, Tsai AC (2014) Impact of geographic and transportation-related barriers on HIV outcomes in sub-Saharan Africa: a systematic review. AIDS Behav 18:1199–1223. https://doi.org/10.1007/s10461-014-0729-8
Laurian Y, Peynet J, Verroust F (1989) HIV infection in sexual partners of HIV-seropositive patients with hemophilia. N Engl J Med 321:268. https://doi.org/10.1056/NEJM198901193200312
Lederman MM, Alter G, Daskalakis DC et al (2010) Determinants of protection among HIV-exposed seronegative persons: an overview. J Infect Dis 202:S333–S338. https://doi.org/10.1086/655967
Lingappa JR, Lambdin B, Bukusi EA et al (2008) Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial. PLoS One 3:e1411–e1411. https://doi.org/10.1371/journal.pone.0001411
Lingappa JR, Kahle E, Mugo NR et al (2009) Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study. PLoS One 4:e5272. https://doi.org/10.1371/journal.pone.0005272
Mackelprang RD, Bosire R, Guthrie BL et al (2014) High rates of relationship dissolution among heterosexual HIV-Serodiscordant couples in Kenya. AIDS Behav 18:189–193. https://doi.org/10.1007/s10461-013-0529-6
Maeri I, El Ayadi A, Getahun M et al (2016) “How can I tell?” consequences of HIV status disclosure among couples in eastern African communities in the context of an ongoing HIV “test-and-treat” trial. AIDS Care 28:59–66. https://doi.org/10.1080/09540121.2016.1168917
Maharaj P, Cleland JG (2005) Risk perception and condom use among married or cohabiting couples in KwaZulu-Natal , South Africa. Int Fam Plan Perspect 31:24–29
Margolis D, González-García J, Stellbrink H-J, et al (2017) Cabotegravir+Rilpivirine as long-acting maintenance therapy: LATTE-2 week 32 results. In: Conference on retroviruses and opportunistic infections. Seattle, WA
Marshall BDL, Paczkowski MM, Seemann L et al (2012) A complex systems approach to evaluate HIV prevention in metropolitan areas: preliminary implications for combination intervention strategies. PLoS One 7:e44833. https://doi.org/10.1371/journal.pone.0044833
Marshall BDL, Friedman SR, Monteiro JFG, Paczkowski M, Tempalski B, Pouget ER, Lurie MN, Galea S (2014) Prevention and treatment produced large decreases in HIV incidence in a model of people who inject drugs. Health Aff 33(3):401–409
Matthews LT, Moore L, Crankshaw TL et al (2014) South Africans with recent pregnancy rarely know partner’s HIV serostatus: implications for serodiscordant couples interventions. BMC Public Health 14:843. https://doi.org/10.1186/1471-2458-14-843
Miller WC, Powers KA, Smith MK, Cohen MS (2013) Community viral load as a measure for assessment of HIV treatment as prevention. Lancet Infect Dis 13:459–464. https://doi.org/10.1016/S1473-3099(12)70314-6
Mills EJ, Bakanda C, Birungi J et al (2011) Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med 155:209. https://doi.org/10.7326/0003-4819-155-4-201108160-00358
Mills EJ, Beyrer C, Birungi J, Dybul MR (2012) Engaging men in prevention and care for HIV/AIDS in Africa. PLoS Med 9:e1001167–e1001167. https://doi.org/10.1371/journal.pmed.1001167
Montaner JSG, Hogg R, Wood E et al (2006) The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 368:531–536
Morin SF, Khumalo-Sakutukwa G, Charlebois ED et al (2006) Removing barriers to knowing HIV status: same-day mobile HIV testing in Zimbabwe. J Acquir Immune Defic Syndr 41:218–224. https://doi.org/10.1097/01.qai.0000179455.01068.ab
Morrison CS, Turner AN, Jones LB (2009) Highly effective contraception and acquisition of HIV and other sexually transmitted infections. Best Pract Res Clin Obstet Gynaecol 23:263–284. https://doi.org/10.1016/j.bpobgyn.2008.11.004
Mugo NR, Heffron R, Donnell D et al (2011) Increased risk of HIV-1 transmission in pregnancy. AIDS 25:1887–1895. https://doi.org/10.1097/QAD.0b013e32834a9338
Mujugira A, Baeten JM, Donnell D et al (2011) Characteristics of HIV-1 Serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention. PLoS One 6:e25828–e25828. https://doi.org/10.1371/journal.pone.0025828
Musheke M, Ntalasha H, Gari S et al (2011) A systematic review of qualitative findings on factors enabling and deterring uptake of HIV testing in sub-Saharan Africa. BMC Public Health 13:13. https://doi.org/10.1186/2046-1682-4-13
Ngure K, Mugo NR, Celum CL et al (2011) A qualitative study of barriers to consistent condom use among HIV-1 serodiscordant couples in Kenya. AIDS Care 24:1–8. https://doi.org/10.1080/09540121.2011.613911
Ngure K, Baeten JM, Mugo NR et al (2014) My intention was a child but I was very afraid : fertility intentions and HIV risk perceptions among HIV-serodiscordant couples experiencing pregnancy in Kenya. AIDS Care 26:1283–1287. https://doi.org/10.1080/09540121.2014.911808
Novitsky V, Moyo S, Mokaleng B, et al (2017) Structure of HIV-1C Transmission Network in Southern Botswana , 2016. In: Conference on Retroviruses and Opportunistic Infections. Seattle, p Abstract 184-Abstract 184
Nsanzimana S, Remera E, Kanters S et al (2015) Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study. Lancet Glob Heal 3:e169–e177. https://doi.org/10.1016/S2214-109X(14)70364-X
of USNI (2013) Sustainable East Africa Research in Community Health (SEARCH) trial
Okano JT, Robbins D, Palk L et al (2016) Testing the hypothesis that treatment can eliminate HIV: a nationwide, population-based study of the Danish HIV epidemic in men who have sex with men. Lancet Infect Dis 16:789–796. https://doi.org/10.1016/S1473-3099(16)30022-6
Organization WH (2013) Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach
Organization WH (2016) HIV self-testing and partner notification: supplement to consolidated guidelines on HIV testing services
Organization WH, (PEPFAR) PEP for AR, Control USC for D et al (2012) Planning, implementing, and monitoring home-based HIV testing and counselling: a practical handbook for Sub-Saharan Africa
Orne-Gliemann J, Larmarange J, Boyer S et al (2015) Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal. BMC Public Health 15:209. https://doi.org/10.1186/s12889-015-1344-y
Passmore JS, Jaspan HB, Masson L (2016) Genital inflammation, immune activation and risk of sexual HIV acquisition. 11:. doi: https://doi.org/10.1097/COH.0000000000000232
Patel P, Borkowf CB, Brooks JT et al (2014) Estimating per-act HIV transmission risk. AIDS 28:1509–1519. https://doi.org/10.1097/QAD.0000000000000298
Petersen M, Balzer L, Kwarsiima D, et al (2016) SEARCH test and treat study in Uganda and Kenya exceeds the UNAIDS 90-90-90 cascade target by achieving over 80% population-level viral suppression after 2 years. In: 21st International AIDS Conference
Piot P, Bartos M, Larson H et al (2008) Coming to terms with complexity: a call to action for HIV prevention. Lancet 372:845–859. https://doi.org/10.1016/S0140-6736(08)60888-0
Polis CB, Curtis KM (2013) Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. Lancet Infect Dis 13:797–808. https://doi.org/10.1016/S1473-3099(13)70155-5
Porter L, Hao L, Bishai D et al (2004) HIV status and union dissolution in sub-Saharan Africa: the case of Rakai, Uganda. Demography 41:465–482. https://doi.org/10.1353/dem.2004.0025
Powers KA, Poole C, Pettifor A, Cohen MS (2008) Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis 8:553–563
Powers KA, Ghani A, Miller WC et al (2011) The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet 378:256–268
Quinn TC, Wawer MJ, Sewankambo N et al (2000) Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai project study group. N Engl J Med 342:921–929
Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S et al (2009) Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361:2209–2220
Rodger AJ, Cambiano V, Bruun T et al (2016) Sexual activity without condoms and risk of HIV transmission in Serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA 316:171. https://doi.org/10.1001/jama.2016.5148
Rosenberg N, Pettifor A, Bruyn G et al (2013) HIV testing and counseling leads to immediate consistent condom use among south African stable HIV-discordant couples. J Acquir Immune Defic Syndr 62:226–233
Roxby AC, Matemo D, Drake AL et al (2013) Pregnant women and disclosure to sexual partners after testing HIV-1–seropositive during antenatal care. AIDS Patient Care STDs 27:33–37. https://doi.org/10.1089/apc.2012.0327
Schwartz SR, Pettifor A, Stuart GS, Cohen MS (2013) Hormonal contraception and HIV: the methods have confused the message. AIDS 27:S45–S53. https://doi.org/10.1097/QAD.0000000000000037
Scott Braithwaite R, Nucifora KA, Toohey C et al (2014) How do different eligibility guidelines for antiretroviral therapy affect the cost-effectiveness of routine viral load testing in sub-Saharan Africa? AIDS 28(Suppl 1):S73–S83. https://doi.org/10.1097/QAD.0000000000000110
Shattock AJ, Kerr CC, Stuart RM et al (2016) In the interests of time: improving HIV allocative efficiency modelling via optimal time-varying allocations. J Int AIDS Soc 19:1–8. https://doi.org/10.7448/IAS.19.1.20627
Skovdal M, Campbell C, Madanhire C et al (2011) Masculinity as a barrier to men’s use of HIV services in Zimbabwe. Glob Health 7:13. https://doi.org/10.1186/1744-8603-7-13
Smith MK, Powers KA, Kashuba ADM, Cohen MS (2011) HIV-1 treatment as prevention: the good, the bad, and the challenges. Curr Opin HIV 6:315–325
Smith MK, Powers KA, Miller WC et al (2012) HIV treatment as prevention: the utility and limitations of ecological observation. PLoS Med 9:e1001260. https://doi.org/10.1371/journal.pmed.1001260
Society-USA IA (2016) Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults 2016 Recommendations of the International Antiviral Society
Sood N, Wagner Z, Jaycocks A, Drabo E, Vardavas R (2013) Test-and-treat in Los Angeles: a mathematical model of the effects of test-and-treat for the population of men who have sex with men in Los Angeles County. Clin Infect Dis 56(12):1789–1796
Stover J, Pretorius C, Bollinger L (2012) The effects of different ART eligibility strategies on HIV-related mortality and incidence. International AIDS conference 2012
Stover J, Andreev K, Slaymaker E et al (2014) Updates to the Spectrum model to estimate key HIV indicators for adults and children. AIDS (London, England) 28(4):S427–S434. https://doi.org/10.1097/QAD.0000000000000483
Suthar AB, Ford N, Bachanas PJ et al (2013) Towards universal voluntary HIV testing and counselling: a systematic review and meta-analysis of community-based approaches. PLoS Med 10:e1001496. https://doi.org/10.1371/journal.pmed.1001496
Tankwanchi ABS, Ozden C, Vermund SH (2013) Physician emigration from sub-Saharan Africa to the United States: analysis of the 2011 AMA physician masterfile. PLoS Med 10:e1001513. https://doi.org/10.1371/journal.pmed.1001513
Tanser F, Bärnighausen T, Grapsa E et al (2013) High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 339:966–971
Thigpen MC, Kebaabetswe PM, Paxton LA et al (2012) Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 367:423–434. https://doi.org/10.1056/NEJMoa1110711
Thirumurthy H, Chamie G, Jain V et al (2013) Improved employment and education outcomes in households of HIV-infected adults with high CD4 cell counts. AIDS 27:627–634. https://doi.org/10.1097/QAD.0b013e32835c54d8
Tao L-L, Liu M, Li S-M, Liu J, Jiang S-L, Wang L-J, Luo F-J, Wang N (2017) Impact of antiretroviral therapy on the spread of human immunodeficiency virus in Chaoyang District, Beijing, China: using the Asian epidemic model. Chin Med J 130(1):32
UNAIDS (2014) 90-90-90 an ambitious treatment target to help end the AIDS epidemic. http://wwwUnaids.Org/Sites/Default/Files/Media_Asset/90-90-90_En_0Pdf40
van Schaik N, Kranzer K, Wood R, Bekker LG (2010) Earlier HIV diagnosis – are mobile services the answer? South Afr Med J 100:671–674
Vargas L, Goicochea P, Casapía M et al (2010) Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 363:2587–2599. https://doi.org/10.1056/NEJMoa1109071
Vernazza P, Hirschel B, Bernasconi E, Flepp M (2008) Les personnes seropositives ne souffrant d’aucune autre MST et suivant un traitment antiretroviral efficace ne transmettent pas le VIH par voie sexuelle. Bull Med suisses 89:165–169
Viljoen L, Thorne M, Thomas A et al (2016) A narrative analysis positioning HIV relative to personal (sexual) relationship challenges in an agony aunt column in the Western Cape, South Africa – aunty Mona’s “love advice”. AIDS Care 28:83–89. https://doi.org/10.1080/09540121.2016.1178957
Volz EM, Frost SDW (2013) Inferring the source of transmission with phylogenetic data. PLoS Comput Biol 9:e1003397–e1003397. https://doi.org/10.1371/journal.pcbi.1003397
Walensky RP, Wolf LL, Wood R et al (2009) When to start antiretroviral therapy in resource-limited settings. Ann Intern Med 151:157–166
Walensky RP, Ross EL, Kumarasamy N et al (2013) Cost-effectiveness of HIV treatment as prevention in Serodiscordant couples. N Engl J Med 369:1715–1725. https://doi.org/10.1056/NEJMsa1214720
Walensky RP, Borre ED, Bekker LG et al (2016a) The anticipated clinical and economic effects of 90-90-90 in South Africa. Ann Intern Med 165:325–333. https://doi.org/10.7326/M16-0799
Walensky RP, Jacobsen MM, Bekker L-G et al (2016b) Potential clinical and economic value of long-acting Preexposure prophylaxis for south African women at high-risk for HIV infection. J Infect Dis 213:1523–1531. https://doi.org/10.1093/infdis/jiv523
Wang L, Ge Z, Jing L et al (2010) HIV transmission risk among serodiscordant couples: a retrospective study of former plasma donors in Henan, China. J Acquir Immune Defic Syndr 55:232–238
Ware NC, Pisarski EE, Haberer JE et al (2015) Lay social resources for support of adherence to antiretroviral prophylaxis for HIV prevention among Serodiscordant couples in sub-Saharan Africa: a qualitative study. AIDS Behav 19:811–820. https://doi.org/10.1007/s10461-014-0899-4
Wasserheit J (1992) Epidemiological synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 19:61–77
Wawer MJ, Gray RH, Sewankambo N et al (2005) Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 191:1403–1409
World Health Organization (2016) Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection Recommendations for a public health approach – Second edition
World Health Organization Assembly (2013) Monitoring the implementation of the WHO global code of practice on the international recruitment of health personnel. Bull World Health Organ 91:816–823. https://doi.org/10.2471/BLT.13.118778
Ying R, Sharma M, Heffron R et al (2015) Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda. J Int AIDS Soc 18. https://doi.org/10.7448/IAS.18.4.20013
Ying R, Sharma M, Celum CL et al (2016) Home testing and counselling to reduce HIV incidence in a generalised epidemic setting: a mathematical modelling analysis. Lancet HIV 3:e275–e282. https://doi.org/10.1016/S2352-3018(16)30009-1
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kumi Smith, M., Jewell, B.L., Hallett, T.B., Cohen, M.S. (2018). Treatment of HIV for the Prevention of Transmission in Discordant Couples and at the Population Level. In: Zhang, L., Lewin, S. (eds) HIV Vaccines and Cure . Advances in Experimental Medicine and Biology, vol 1075. Springer, Singapore. https://doi.org/10.1007/978-981-13-0484-2_6
Download citation
DOI: https://doi.org/10.1007/978-981-13-0484-2_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-0483-5
Online ISBN: 978-981-13-0484-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)